PT Bundamedik Tbk
BMHS.JK
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.69T
Close$
Share Statistics
| Market cap | $1.69 Trillion |
|---|---|
| Enterprise Value | $2.97 Trillion |
| Dividend Yield | $1.03 (0.52%) |
| Earnings per Share | $1.66 |
| Beta | -0.19 |
| Outstanding Shares | 8,603,416,000 |
Return
| Return on Equity | -0.06% |
|---|---|
| Return on Assets | -0.03% |
| Return on Invested Capital | 2.53% |
Valuation & Multiples
| P/E Ratio | -1606.85 |
|---|---|
| PEG | 98.32 |
| Price to Sales | 1.06 |
| Price to Book Ratio | 0.72 |
| Enterprise Value to Revenue | 1.83 |
| Enterprise Value to EBIT | 34.52 |
| Enterprise Value to Net Income | -2729 |
| Total Debt to Enterprise | 0.51 |
| Debt to Equity | 0.78 |
Revenue Sources
No data
Insider Trades
Next Earnings Call
Expected Date
November 3, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About PT Bundamedik Tbk
1,789 employees
CEO: Agus Heru Darjono Operating as a key healthcare provider in Indonesia, PT Bundamedik Tbk (also known as PT Bunda Medik) had a significant footprint as of December 31, 2021. Its facilities included two maternal and child hospitals, three general hospitals,...